These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration. Derk J; MacLean M; Juranek J; Schmidt AM J Alzheimers Dis Parkinsonism; 2018; 8(1):. PubMed ID: 30560011 [No Abstract] [Full Text] [Related]
8. Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components. Sadowska-Bartosz I; Galiniak S; Bartosz G Molecules; 2014 Nov; 19(11):18828-49. PubMed ID: 25407721 [TBL] [Abstract][Full Text] [Related]
9. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach. Salahuddin P; Rabbani G; Khan RH Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Sadowska-Bartosz I; Galiniak S; Bartosz G Molecules; 2014 Apr; 19(4):4880-96. PubMed ID: 24747646 [TBL] [Abstract][Full Text] [Related]
11. Role of methylglyoxal in Alzheimer's disease. Angeloni C; Zambonin L; Hrelia S Biomed Res Int; 2014; 2014():238485. PubMed ID: 24734229 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. Zhang Q; Monroe ME; Schepmoes AA; Clauss TR; Gritsenko MA; Meng D; Petyuk VA; Smith RD; Metz TO J Proteome Res; 2011 Jul; 10(7):3076-88. PubMed ID: 21612289 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers in amyotrophic lateral sclerosis: facts and future horizons. Pradat PF; Dib M Mol Diagn Ther; 2009; 13(2):115-25. PubMed ID: 19537846 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress biomarkers in sporadic ALS. Mitsumoto H; Santella RM; Liu X; Bogdanov M; Zipprich J; Wu HC; Mahata J; Kilty M; Bednarz K; Bell D; Gordon PH; Hornig M; Mehrazin M; Naini A; Flint Beal M; Factor-Litvak P Amyotroph Lateral Scler; 2008 Jun; 9(3):177-83. PubMed ID: 18574762 [TBL] [Abstract][Full Text] [Related]
15. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762 [TBL] [Abstract][Full Text] [Related]
16. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord. Kikuchi S; Shinpo K; Ogata A; Tsuji S; Takeuchi M; Makita Z; Tashiro K Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):63-8. PubMed ID: 12215227 [TBL] [Abstract][Full Text] [Related]
17. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013 [TBL] [Abstract][Full Text] [Related]